DJIA 16,804.71 -238.19 -1.40%
NASDAQ 4,422.09 -71.31 -1.59%
S&P 500 1,946.16 -26.13 -1.32%
market minute promo

131.67 0.47 (0.36%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $131.67 0.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $131.12
Previous Close $131.20
Daily Range $128.64 - $131.95
52-Week Range $102.60 - $153.10
Market Cap $43.9B
P/E Ratio -55.83
Dividend (Yield) $0.00 (0.0%)
Volume 3,723,608
Average Daily Volume 2,318,591
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary

3 Questions for Allergan Inc.

Allergan is fighting tooth and nail to remain independent from Valeant Pharmaceuticals. Here are three questions investors should know the answers to heading into what is looking like the endgame.

A Bizarre Pharma Love Triangle

Sector Update: Health Care Stocks Largely Resist Late-Afternoon Decline; Portola Pharma Climbs 16% O

Sector Update: Health Care Stocks Largely Resist Late-Afternoon Decline; Portola Pharma Climbs 16% On Positive Results for Drug

Sector Update: Health Care

QLT Left At The Altar

Valeant's Bausch + Lomb Announces Results on Lotemax - Analyst Blog

Today's Stocks Driving Success For The Drugs Industry

UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'

Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog

Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog

Why Allergan (AGN) Stock Is Declining in After-Hours Trading Today

See More VRX News...

VRX's Top Competitors

VRX $131.67 (0.36%)
Current stock: VRX
JNJ $104.30 (-2.15%)
Current stock: JNJ
PFE $29.15 (-1.42%)
Current stock: PFE
NVS $93.22 (-0.97%)
Current stock: NVS